Across TCGA pan-cancer cohorts, VIM2P RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of VIM2P’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where VIM2P RNA is repressed in tumor relative to normal tissue. In most cancer types VIM2P is over-expressed in tumor, although a few such as BRCA and COAD show the opposite, repressed pattern.

BRCA, COAD, and READ are the cancer types where VIM2P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in VIM2P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	−0.054	.001	2	view →
COAD	Female	II,III,IV	−0.014	.041	2	view →
READ	Female	All	−0.038	.047	1	view →
THCA	All	All	−0.009	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: VIM2P RNA expression & survival · all VIM2P data types